Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
about
Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.Pernicious Anemia Associated Cobalamin Deficiency and Thrombotic Microangiopathy: Case Report and Review of the LiteratureCauses and risk factors of death in patients with thrombotic microangiopathies.Unresponsive thrombotic thrombocytopenic purpura in critically ill adults.Management and outcomes for patients with TTP: analysis of 100 cases at a single institution.Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency.How we approach an acquired thrombotic thrombocytopenic purpura patient.Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed?Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center.Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease.Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study.Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.Therapeutic dilemma in the management of a patient with the clinical picture of TTP and severe B12 deficiency.Assessment of endothelial damage and cardiac injury in a mouse model mimicking thrombotic thrombocytopenic purpura.Increased troponin I is associated with fatal outcome in acquired thrombotic thrombocytopenic purpura.Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk FactorsCaplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura.ADAMTS13 Levels in Young Patients With β-Thalassemia Major: Relation to Hepatitis C Virus Infection, Liver Cirrhosis, and Iron Overload.Response to "Predictors of survival in thrombotic thrombocytopenic purpura" Haematologica 2013;98(5):e58.Predictors of survival in thrombotic thrombocytopenic purpura.Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China.Thrombotic thrombocytopenic purpura
P2860
Q31077457-EF7DD8DF-1729-4D8C-9D1A-52F6A1C8DC90Q33168354-C6BF3749-2484-4783-9AA2-BB055F608634Q33402347-D8B6CDC2-6C7E-4830-AA4C-B0E9A8048A53Q33406785-703E09D9-16D0-40CF-A6A9-21C890A61540Q33407187-419B9A01-8C95-47E9-BC58-5727693CC596Q33409028-D3F8AC5A-A010-42F7-BBAF-2917BC47180CQ33416780-4CC3C294-5B17-4221-AA17-FCA1A95CA30FQ33417543-938347CF-50E5-42C4-A142-3F66647507EBQ33418732-F533867D-B3B2-45DA-91DD-719020A1DC33Q33423670-1209A400-EBE3-4B93-9251-27F1590B8F57Q33424405-A0236DB7-3510-460B-9342-8F0BF9EDA57BQ33427885-17366FA9-687F-48D6-B359-5FBA494623D0Q33428134-E99C7B36-B816-457E-8CC0-B726BD2D2B40Q33434431-88AFE7C2-75B1-440D-A33F-BB87FFE8C2ADQ33435833-C07F97AD-49D3-4963-86ED-0A9AB18F9262Q33436972-A804E072-AE53-4234-9871-0CC7B4A1C723Q36068855-23A30842-A475-49F4-B38D-FF3B411A10ABQ38818496-2C53248B-02FC-4710-B2CC-9F98E9B6054BQ41645162-2DF0DA6A-40F4-4447-A078-42E76331290EQ43111386-3828D093-F807-4501-936D-4C4B8F6D53FBQ43181362-A5FFDDF0-B571-4BFA-93E5-BF8F54A32781Q51116023-0A43A61A-FAB1-4A09-B99B-80A717D5FF32Q57379903-790E0D44-9E1D-4120-BE7E-BFD14CED25C4
P2860
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Development and validation of ...... A Reference Center experience.
@ast
Development and validation of ...... A Reference Center experience.
@en
type
label
Development and validation of ...... A Reference Center experience.
@ast
Development and validation of ...... A Reference Center experience.
@en
prefLabel
Development and validation of ...... A Reference Center experience.
@ast
Development and validation of ...... A Reference Center experience.
@en
P2093
P2860
P50
P1433
P1476
Development and validation of ...... A Reference Center experience.
@en
P2093
Agnès Veyradier
Alain Wynckel
Bertrand Guidet
Christiane Mousson
Claire Pouteil-Noble
Claire Presne
Cyrielle Assié
Cécile Vigneau
Cédric Daubin
Didier Gruson
P2860
P304
P356
10.3324/HAEMATOL.2011.049676
P577
2012-05-11T00:00:00Z